Overview
Hypertrophic cardiomyopathy (HCM) is a common heart condition that affects approximately 1 in 500 people worldwide. It is a genetic disorder that causes the heart muscle to thicken, leading to abnormal heart function and potentially life-threatening complications. HCM can affect people of all ages, but it is most commonly diagnosed in young athletes. The condition is often inherited, but it can also occur spontaneously.
HCM is a complex condition that involves the thickening of the heart muscle, particularly in the left ventricle. This thickening can lead to a narrowing of the heart's chambers, making it harder for blood to flow out of the heart and into the body. As a result, the heart may become overworked, leading to fatigue, shortness of breath, and other symptoms.
History/Background
The first descriptions of HCM date back to the 19th century, when physicians noted the presence of a "hypertrophied" heart in patients with sudden cardiac death. However, it wasn't until the 1960s that the condition was formally described and recognized as a distinct entity. Since then, significant advances have been made in understanding the genetics, pathophysiology, and treatment of HCM.
Key Information
HCM is a genetic condition that is caused by mutations in genes that code for proteins involved in the structure and function of the heart muscle. The most common genes associated with HCM are MYBPC3, MYH7, and TNNT2. The condition can be inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition.
Symptoms of HCM can vary widely and may include:
* Chest pain or discomfort
* Shortness of breath
* Fatigue
* Dizziness or lightheadedness
* Palpitations or irregular heartbeats
* Syncope (fainting)
Physical examination and imaging tests, such as echocardiography and cardiac MRI, are used to diagnose HCM. Treatment options may include medications to manage symptoms, implantable cardioverter-defibrillators (ICDs) to prevent sudden cardiac death, and surgical procedures to relieve obstruction and improve heart function.
Significance
HCM is a significant public health concern due to its high prevalence and potential for sudden cardiac death. According to the American Heart Association, HCM is the leading cause of sudden cardiac death in young athletes. Early diagnosis and treatment can significantly improve outcomes and reduce the risk of complications.
